Monday - October 19, 2026

Gastric Cancer Pipeline 2026: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight | Eli Lilly and Company, BeiGene, Hutchison MediPharma, Astellas Pharma

(Albany, New York) – October 19, 2026: As per DelveInsight’s assessment, globally, Gastric Cancer pipeline constitutes 200+ key companies continuously working towards developing 220+ Gastric Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Cutaneous Lupus Erythematosus Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | Biogen, Horizon Therapeutics, Bristol–Myers Squibb

The Key Cutaneous Lupus Erythematosus Companies in the market inlcude – Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen, Biogen, Gilead Sciences, Pfizer, Bristol-Myers Squibb, Novartis, Rigel Pharmaceuticals, Merck, and others. (Albany, New York) – October 19, 2026: DelveInsight’s “Cutaneous … Continue reading →

PD-1 NSCLC Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Genor Biopharma, Shandong Boan Biotech, Pfizer, AstraZeneca, Lepu Biopharma, GSK

(Albany, New York) – October 19, 2026: As per DelveInsight’s assessment, globally, PD-1 Non-Small Cell Lung Cancer pipeline constitutes 25+ key companies continuously working towards developing 30+ PD-1 Non-Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism … Continue reading →

Aplastic Anemia Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast – DelveInsight | Pfizer, Regeneron Pharma, Gamida-Cell, Kyowa Kirin, Novartis, Jiangsu HengRui

The Key Aplastic Anemia Companies in the market include – Teva Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals, Gamida-Cell, Kyowa Kirin, Novartis, Jiangsu HengRui Medicine Co., Ltd., Janssen Scientific Affairs, LLC, and others. (Albany, New York) – October 19, 2026: DelveInsight’s “Aplastic Anemia … Continue reading →

Celiac Disease Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Zedira, Dr. Falk Pharma, Takeda, ImmunoGenX, Provention Bio, Sanofi

The Key Celiac Disease Companies in the market include – Takeda, AnokionSA, Mozart Therapeutics, AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical Co., Ltd., Calypso Biotech, ImmunogenX, Inc., Amgen Inc., and others. (Albany, New York) – October 19, 2026: DelveInsight’s “Celiac … Continue reading →

Nasopharyngeal Carcinoma Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | BieGene, Famitinib, Tessa Therapeutics, Chia Tai Tianqing Pharma

The Key Nasopharyngeal Carcinoma Companies in the market include – Akeso Tiancheng, Inc, Chia Tai Tianqing Pharmaceutical, Hoffmann-La Roche, Novartis, Jiangsu HengRui Medicine, Qilu Pharmaceutical, Akeso, Bristol-Myers Squibb, Sanofi, Innovent Biologics (Suzhou) Co. Ltd., Eli Lilly and Company, and others. … Continue reading →